Efficacy of tocilizumab combined with glucocorticoid in the treatment of Takayasu arteritis in infants

Figures & data

Table 1. Clinical manifestations and laboratory results of eight children from the time of diagnosis.

Number of cases, N	8
Age of onset (days)	92 ± 24
Body temperature before drug intervention (°C)	39.0 ± 0.6
Fever, n (%)	8 (100)
Time from onset to diagnosis (days)	21 ± 9
WBC count (×10^9/L)	15.2 ± 3.9
CRP (mg/L)	87.8 ± 33.6
ESR (mm/h)	72 ± 18
IL-6 (pg/mL)	162.5 ± 122.7

Data are shown as mean ± sd unless otherwise specified.

WBC, white blood cell; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IL-6, interleukin-6.

Table 2. Summary of children’s growth data at follow-up in October 2022.

Case	Age	Sex	Height/weight (cm/kg)	For reference: standard height/weight (cm/kg)
1	1 year, 6 months	Male	77/11	79.6/11.29
2	1 year, 6 months	Female	78/12	78.5/10.65
3	3 years, 1 month	Female	87/14	88.9/14.13
4	3 years, 3 months	Male	86/14	91.2/15.15
5	2 years, 2 months	Female	84/12.5	82.7/12.5
6	2 years, 10 months	Female	82/12	90.5/12.18
7	2 years, 6 months	Female	84/11.8	84.8/11.7
8	3 years, 8 months	Female	94/15	93.7/14

Data availability statement

All data generated or analysed during this study are included in this article. Further enquiries can be directed to the corresponding author.